LGBTQ+ Advisory Group Accelerates Airmen's Return to Flight with HIV Drug Change

The U.S. Air Force has revised its policies regarding the use of an anti-HIV drug, reducing the grounding period for pilots taking the medication from 30 days to 14 days and eliminating the need for waivers for aircrews. The change, initiated by the Air Force's LGBTQ+ Initiative Team, aims to enhance readiness and retain service members. The new policy aligns with CDC guidelines for HIV Pre-Exposure Prophylaxis (PrEP), a preventative medication that reduces the risk of contracting the virus. The Pentagon currently prohibits individuals who have tested positive for HIV from joining the military but allows diagnosed service members to continue serving.